CAS No. |
100665-43-8 |
中文名称 |
(E)-6-((5R,7S,10S,13R,14R,17R)-7-羟基-4,4,10,13,14-五甲基-3,11,1,15-三氧代-2,3,4,5,6,7,10,11,12,13,14,15,16,17-十四氢-1H-环戊并[a]菲-17-基)-2-甲基-4-氧代庚-5-烯酸 |
英文名称 |
(E)-6-((5R,7S,10S,13R,14R,17R)-7-Hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxohept-5-enoic acid |
别名 |
(20E)-7β-Hydroxy-3,11,15,23-tetraoxo-5α-lanosta-8,20(22)-dien-26-oic acid;(20E)-7β-Hydroxy-3,11,15,23-tetraoxolanosta-8,20(22)-diene-26-oic acid;(7beta,20E)-7-Hydroxy-3,11,15,23-tetraoxolanosta-8,20(22)-dien-26-oic acid;Ganoderenic acid d;Apoptosis,Inhibitor,inhibit,Ganoderenic acid D;(E)-6-((5R,7S,10S,13R,14R,17R)-7-Hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxohept-5-enoic acid;Lanosta-8,20(22)-dien-26-oic acid, 7-hydroxy-3,11,15,23-tetraoxo-, (7β,20E)- |
标准英文名 |
(E)-6-((5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxohept-5-enoic acid |
MDL No. |
- |
分子式 |
C30H40O7 |
分子量 |
512.64
|
精确分子量 |
512.28
|
SMILES |
C/C(=C\C(=O)CC(C)C(=O)O)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)C[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O |
标准SMILES |
CC1(C)[C@@H]2C[C@H](O)C3=C(C(=O)C[C@]4(C)[C@H](CC(=O)[C@]43C)/C(/C)=C/C(=O)CC(C)C(O)=O)[C@@]2(C)CCC1=O |
用途 |
Ganoderenic acid D is a triterpenoid extracted from Ganoderma lucidum, exhibiting anticancer activity by inducing cell cycle arrest and apoptosis to inhibit cancer cell proliferation. |
InChIKey |
JGWQYLZHPPFHEH-OWDPHXCRSA-N |